CAS NO: | 1380723-44-3 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | Atezolizumab (MPDL3280A) is a selective humanized monoclonalIgG1antibody against programmed death ligand 1 (PD-L1), used forcancerresearch. |
体外研究 (In Vitro) | Atezolizumab (0, 2.5, 5, 10, 20, and 40 μg/ml; 24 hours; HOS and 143B cells) inhibits proliferation and induces immune-independent apoptosis of osteosarcoma cells[1]. |
Clinical Trial | |
分子量 | 144590.50 |
性状 | Liquid |
CAS 号 | 1380723-44-3 |
中文名称 | 阿特珠单抗;阿替利珠单抗 |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |